An Overview of EuroQol EQ-5D: Quality-of-Life Assessment
EuroQol EQ-5D explained: How it measures quality of life, supports QALYs and HTA decisions, and what new EuroQol tools mean for clinical trial strategy.
Shahid S. Siddiqui, MS, PhD is a molecular biologist, precision medicine innovator, and regulatory affairs strategist with more than four decades of biomedical research experience spanning six countries. Founder and CEO of McGenome, LLC, he develops race-calibrated AI/ML diagnostic platforms including SarcoActivity™ for sarcoidosis. His career spans the Max-Planck-Institute, Northwestern University, Toyohashi University of Technology, UIC, the University of Chicago, and Umm Al-Qura University. He is Professor of Foundational Sciences at Niazee College of Osteopathic Medicine and has authored 100+ publications in Nature, Science, PNAS, and other leading journals.
This member hasn't published any content yet. Check back later for articles, podcasts, and more.